The investment — a personal donation separate from the Bill and Melida Gates Foundation — will include $50 million to the Dementia Discovery Fund and $50 million to start-up companies focused on Alzheimer’s research.
The Dementia Discovery Fund is a venture capital fund that brings together government entities and pharmaceutical companies to advance research and find treatments for dementia.
“[Dementia] is a huge problem, a growing problem, and the scale of the tragedy — even for the people who stay alive — is very high,” Mr. Gates told Reuters.
Mr. Gates said he is optimistic about finding a treatment with focused and well-funded innovation.
More articles on population health:
AMA expands program to reduce incidence of Type 2 diabetes
New Oregon health clinic to offer transitional, permanent housing
10 worst states for STDs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
